MedPath

En Bloc TURBT With Collins Loop vs Conventional TURBT

Not Applicable
Conditions
Bladder Cancer
Bladder Cancer Stage
Bladder Urothelial Carcinoma
Bladder Neoplasm
Urothelial Carcinoma Recurrent
Registration Number
NCT05027412
Lead Sponsor
Hospital Universitario de Fuenlabrada
Brief Summary

This is a prospective, randomized, randomized and single-blind study in patients diagnosed with primary bladder CV. Patients diagnosed by cystoscopy of a bladder tumor and with indication for endoscopic surgical treatment, who meet the inclusion criteria, and who sign the Informed Consent (IC), will be randomized.

Detailed Description

The main objective of the study is to assess the quality of the resection, defined as the presence of detrusor muscle in the resected tissue.

The secondary objetives are:

* Compare the surgical time, hospital stay, urinary catheterization time and incidence of complications.

* Compare tumor recurrence after one year of follow up.

* Determine the number of re-TURB as a consequence of the absence of muscle layer in the sample or artifacts (Tx)

* Establish the incidence of conversions as a consequence of difficulties in the technique or intraoperative bleeding.

* Compare the degree of satisfaction of the surgeon

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • >18 years old.
  • Polypoid / sessile primary tumor.
  • < 3 tumors
  • Tumor size 10 - 30 mm.
Exclusion Criteria
  • > 4 tumors
  • Size of the largest tumor <1 cm and> 4 cm.
  • Tumor located in the bladder dome.
  • No visualization of the ureteral meatus.
  • Flat or in situ tumor.
  • Non-urothelial tumors.
  • Clotting disorder or treatment with oral anticoagulants.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
presence of detrusor muscle in the resected sample1 year of follow up

yes/no

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital Universitario de Fuenlabrada

🇪🇸

Fuenlabrada, Madrid, Spain

Hospital Universitario de Fuenlabrada
🇪🇸Fuenlabrada, Madrid, Spain
Hugo Otaola Arca, M.D., Ph.D.
Principal Investigator
Manuel Álvarez Ardura, M.D.
Principal Investigator
Álvaro Páez Borda, M.D., Ph.D.
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.